Open Access

The Case for Open Access Open Access (OA) stands for unrestricted access and unrestricted reuse. Here’s why that matters. Most publishers own the rights to the articles in their journals. Although many researchers can access the journals they need via their institution and think that their access is free, in reality it is not. Paying for access to content makes sense in the world of print publishing, where providing content to each new reader requires the production of an additional copy, but online it makes much less sense to charge for content when it is possible to provide access to all readers anywhere in the world. PLOS Takes a Different Approach PLOS applies the Creative Commons Attribution (CC BY) license to works we publish. Benefits of Open Access Research Accelerated discovery. Additional OA Resources

A few Religious Studies articles showing up in SAGE Open open access “mega journal”; reviewers being solicited « Omega Alpha | Open Access The other day I received an email from a librarian colleague who is also a scholar in New Testament. He considers himself an “under-employed Ph.D.,” by which I gather means having the academic credentials but not a full teaching position. I don’t know the circumstances of his situation, but I do know he is not alone. His email was interesting on a number of levels. These are important questions that I want to follow-up with in a subsequent post. What is SAGE Open? The model for SAGE Open appears to be PLoS ONE, a multidisciplinary open access science “mega journal” (particularly for the life-sciences and medicine) published by Public Library of Science, the now renowned non-profit open access science journal publisher. SAGE has had a program in place for some time which enables authors to pay a fee to make their articles open access, particularly to comply with mandated archiving policies by funding agencies. A few Religious Studies articles showing up in SAGE Open I paid it myself.

DOAB: Directory of Open Access Books Open Science and its role in universities: a roadmap for cultural change | LERU Open Science opens up new ways in which research/education/innovation are undertaken, archived and curated, and disseminated across the globe. Open Science is not about dogma per se; it is about greater efficiency and productivity, more transparency and a better response to interdisciplinary research needs. The LERU universities are convinced Open Science brings new and exciting opportunities for the scholarly community and for how academics interact with society. They also realise, however, that this transition will not be straightforward to deliver. There are challenges that lie ahead. The LERU universities fully acknowledge that Open Science represents a complex and multi-dimensional process of transition, different for every university.

Current Therapeutic Research - Moving to Gold Open Access Model from January 2013 Current Therapeutic Research - Change to Gold Open Access Model >> Submit your paper Current Therapeutic Research serves an international audience of scientists and clinicians in a variety of research, academic and clinical practice settings by quickly disseminating research findings.The journal provides a home for the rapid publication of: Original reports of recent development in drug therapy, including papers presenting unexpected, controversial, provocative and/or negative results Research letters, presenting research that may stimulate further investigation or alert readers to clinically relevant but preliminary findings In-depth review articles on specific drug therapies or disease states Applied health economics papers, aimed at a clinical audience Trials From Resource-Limited Settings intended to highlight original medical and pharmaceutical reports from resource-limited settings. Editor-in-Chief: Roger Bullock

Tom Hulme: 'Open-source your product to unlock its full potential' This article was taken from the February 2013 issue of Wired magazine. Be the first to read Wired's articles in print before they're posted online, and get your hands on loads of additional content by subscribing online. Play-Doh was originally invented in the US as a wallpaper cleaner in the 1930s. It wasn't for another 20 years that the nephew of its inventor Noah McVicker repurposed the putty as clay for pre-schoolers and rebranded it Play-Doh. It remains popular today. Contrast this with another putty blob, Sugru, invented in 2003 by a postgraduate student at The Royal College of Art in London. The difference between the businesses is that Sugru is designed for emergence. As it becomes harder to predict how new products and services will be received by customers, we need to allow our strategies, products, brands and services to emerge based on real developing needs. This approach is increasingly common. If Torvalds had been left to work on Linux alone, it wouldn't be as successful.

Open Access Journals Search Engine (OAJSE) La mondialisation de la recherche - Bibliothèques de recherche et mondialisation - Collège de France 1 Lucien Febvre et Henri-Jean Martin, L’Apparition du livre, Paris, Albin Michel, 1958 ; nouvelle édi (...) 1« Le livre, ce ferment, cet objet, cette marchandise »1, c’est à cette analyse globale que nous conviait naguère Henri-Jean Martin et à laquelle on peut encore se référer pour décrire les bouleversements qui transforment le monde académique et, partant, les bibliothèques de recherche. Résumons schématiquement trois tendances lourdes qui modifient les conditions de conception des textes scientifiques, les formes qui dominent leur transmission et, par conséquent, les modes de leur réception : 2 Les chiffres cités sur l’édition scientifique proviennent pour l’essentiel du rapport Outsell 2009 (...) 4J’énumère quelques exemples, sur certains desquels je reviendrai par la suite. 5Acquisitions. 3 Ainsi une enquête de 2003 sur les étudiants en lettres et sciences humaines de la région parisienne (...) La mondialisation de l’information scientifique et les effets de la concentration 10 Cf.

Journal of Neuropsychiatric Disease and Treatment - Dove Press Neuropsychiatric Disease and Treatment Open access peer-reviewed scientific and medical journals. Open Access Dove Medical Press is now a member of the Open Access Initiative A guide to help authors get their paper published. Support Open Access and Dove Press Promotional Article Monitoring - further details Real benefits for authors, including fast-track processing of papers. (4,820,110) Views ISSN 1178-2021 (Online) An international, peer-reviewed journal of clinical therapeutics and pharmacology focusing on concise rapid reporting of clinical or pre-clinical studies on a range of neuropsychiatric and neurological disorders. Journal Impact Factor: 2.000 This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE). Indexed online: Article Processing Statistics: 15 From submission of manuscript to first editorial decision (including peer-review) 33 From editorial acceptance to publication Do you access dovepress.com via your: